Target intelligence / Profile preview

DNA cross-linking reagent

Molecular classification
Other (chemical reagent/class of compounds), Not a single molecular target, but a class of chemical agents
01

Overview

DNA cross-linking reagents are not individual molecular targets but rather a broad class of chemical compounds capable of covalently linking two nucleotides within the same strand (intrastrand) or across complementary strands (interstrand) in double-stranded DNA. These reagents include both natural and synthetic chemicals—such as alkylating agents (e.g., nitrogen mustards), platinum-based drugs (e.g., cisplatin), mitomycins, and psoralens—that disrupt essential cellular processes by preventing proper unwinding or separation of the genetic material during replication and transcription. The resulting lesions can trigger cell cycle arrest and apoptosis if unrepaired. Because rapidly dividing cancer cells are particularly susceptible to this type of damage, many clinically important chemotherapeutic drugs act via this mechanism. However, their use is limited by significant toxicity due to effects on healthy proliferative tissues[1][2][4]. Note: "DNA cross-linking reagent" is not itself a protein target such as an enzyme or receptor; it refers instead to a functional group/classification for small molecules used primarily in research or therapy. If you require information about specific protein targets affected by these reagents—such as particular repair enzymes involved in resolving these lesions—please specify further.

Other names
DNA crosslinkerDNA cross-linking agentDNA interstrand crosslinking agentAlkylating agent (when referring to a subclass)Platinum-based chemotherapeutic (for some agents)
02

Mechanism of action

Covalent binding to nucleotides within or between strands of the DNA double helix, forming intra-strand or inter-strand crosslinks that block replication and transcription[1][2][4]

03

Biological functions

Induction of DNA damageInhibition of DNA replication and transcriptionInduction of cell cycle arrest and apoptosis
04

Disease associations

Cancer (as therapeutic agents in chemotherapy)Other (potential for use in research on genomic stability, mutagenesis)
05

Safety considerations

High toxicity due to non-specific targeting; can damage normal rapidly dividing cells leading to side effects such as myelosuppression, nephrotoxicity, neurotoxicity[2]
06

Interacting drugs

Cisplatin

5 more in the full profile.

Beyond the preview

Go deeper on DNA cross-linking reagent.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA cross-linking reagent.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call